LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Research Center for Molecular Medicine of the Austrian Academy of Sciences
Headquarters:
Vienna, Austria
Website:
http://www.cemm.oeaw.ac.at/
Year Founded:
2005
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Mar 6, 2021
Emerging Company Profile
Proxygen’s knockout take on targeted protein degradation
Emerging Company Profile: Vienna’s Proxygen is taking a ligase-agnostic approach to finding molecular glues with therapeutic effects
Read More
BioCentury
|
Feb 1, 2018
Emerging Company Profile
Non-adherence policy
How Allcyte images B and T cell interactions to predict drug response
Read More
BioCentury
|
Jan 3, 2017
Distillery Therapeutics
Infectious disease
Read More
BioCentury
|
Apr 24, 2014
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Apr 21, 2014
Company News
Qiagen, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences deal
Read More
BioCentury
|
Apr 17, 2014
Cover Story
Contaminating cancer genomes
Read More
BioCentury
|
Jan 23, 2014
Distillery Therapeutics
Indication: Hematology
Read More
BioCentury
|
Sep 26, 2013
Distillery Techniques
Technology: Disease models
Read More
BioCentury
|
Sep 26, 2013
Tools & Techniques
Trapping human genes
Read More
BioCentury
|
Jun 10, 2013
Company News
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Central European Institute of Technology (CEITEC), Centre for Genomic Regulatio
Read More
Items per page:
10
1 - 10 of 16